Position in ASND
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$496,766,798
+$27,424,735 QoQ
Shares Held
1,862,503
-9.2% QoQ
Ownership
2.84%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#11
of 308 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,179,114,031 across 176 Biotechnology names. ASND ranks #3 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
This page
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
|
224,930 | $208,683,303 |
All Filings in ASND
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $496,766,798 | 1,862,503 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $469,342,063 | 2,051,948 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $407,305,243 | 1,910,079 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $316,099,150 | 1,589,956 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $302,648,575 | 1,753,468 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $255,629,257 | 1,640,121 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $186,737,927 | 1,356,417 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $217,951,238 | 1,459,723 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $284,331,977 | 2,084,851 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $299,599,134 | 1,981,869 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $134,112,189 | 1,064,805 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $113,612,007 | 1,213,285 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $108,289,255 | 1,213,325 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $144,307,826 | 1,345,904 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $168,236,760 | 1,377,522 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $119,171,539 | 1,154,092 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $89,059,119 | 958,037 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $108,168,482 | 921,681 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $123,688,630 | 919,413 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $132,247,636 | 829,711 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $104,485,297 | 794,263 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $94,388,490 | 732,375 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $122,093,467 | 732,063 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $110,405,620 | 715,433 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $103,240,559 | 698,043 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $78,845,017 | 700,160 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||